Newer oral anticoagulants reduce event risk in AF, GI bleeding vs. warfarin

Non-vitamin K antagonist oral anticoagulants conferred lower risk for ischemic stroke and major bleeding in patients with atrial fibrillation and a history of gastrointestinal bleeding compared with warfarin, according to study results.“Oral anticoagulant therapy is essential for the prevention of thromboembolic events in patients with AF. The introduction of non-vitamin K antagonist oral anticoagulants has facilitated uptake of thromboprophylaxis,” Soonil Kwon, MD, from Seoul National University Hospital in South Korea, and colleagues wrote. “However, the effectiveness andRead More

Share on facebook
Share on twitter
Share on linkedin